Graf Acquisition Corp. IV
closedU=S+W/3W=S@11.50
NKGN
Capital Structure & Economics
Trust Size$150,000,000
Unit Price$10.00
Warrant Coverage1/3
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
33% Warrant Inclusion| Public Trust Allocation | $150,000,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $10.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedFeb 23, 2021
SearchingTarget Pending
Maturation Wall
N/A
Announced Target / M&A
- Target CompanyNKGen Biotech, Inc.
- SectorBiotechnology
- Announced Deal Size$161,600,000
Board & Officers
- Paul Y. Song, M.D.CEO
- Officer
- Paul Song, M.D.Director
- Yong Man Kim, Ph.D.Director
- Pierre GagnonDirector
- Michael KlowdenDirector
- Kathleen ScottDirector
- Sangwoo ParkDirector
Advanced Structuring Terms
| Target Sectors | Biotechnology |
Syndicate & Advisors
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.